Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background/Aims: The distribution of hepatitis C virus (HCV) genotypes varies geographically. In Korea, genotypes 1and 2 comprise more than 90% of HCV infections, while genotype 6 is very rare. This study compared the clinical and epidemiological characteristics of patients with genotype 6 HCV infection with those infected with HCV genotypes 1and 2. Methods: This was a prospective, multicenter HCV cohort study that enrolled 1,173 adult patients, of which 930underwent HCV genotype analysis, and only 9 (1.0%) were found to be infected with genotype 6 HCV. The clinical and epidemiological parameters of the genotypes were compared. Results: The patients with genotype 6 HCV had a mean age of 41.5 years, 77.8% were male, and they had no distinct laboratory features. A sustained virologic response (SVR) was observed in four (67%) of six patients who received antiviral therapy. Risk factors such as the presence of a tattoo (n=6, 66.7%), more than three sexual partners (n=3, 33.3%), and injection drug use (n=3, 33.3%) were more common among genotype 6 patients than among genotypes 1 or 2. Conclusions: The epidemiology and treatment response of patients infected with genotype 6 HCV differed significantly from those with genotypes 1 or 2, warranting continuous monitoring. (Clin Mol Hepatol 2013;19:45-50)
Abstract
Background/Aims: The distribution of hepatitis C virus (HCV) genotypes varies geographically. In Korea, genotypes 1and 2 comprise more than 90% of HCV infections, while genotype 6 is very rare. This study compared the clinical and epidemiological characteristics of patients with genotype 6 HCV infection with those infected with HCV genotypes 1and 2. Methods: This was a prospective, multicenter HCV cohort study that enrolled 1,173 adult patients, of which 930underwent HCV genotype analysis, and only 9 (1.0%) were found to be infected with genotype 6 HCV. The clinical and epidemiological parameters of the genotypes were compared. Results: The patients with genotype 6 HCV had a mean age of 41.5 years, 77.8% were male, and they had no distinct laboratory features. A sustained virologic response (SVR) was observed in four (67%) of six patients who received antiviral therapy. Risk factors such as the presence of a tattoo (n=6, 66.7%), more than three sexual partners (n=3, 33.3%), and injection drug use (n=3, 33.3%) were more common among genotype 6 patients than among genotypes 1 or 2. Conclusions: The epidemiology and treatment response of patients infected with genotype 6 HCV differed significantly from those with genotypes 1 or 2, warranting continuous monitoring. (Clin Mol Hepatol 2013;19:45-50)
참고문헌 (16)
- Simmonds P, "Genetic diversity and evolution of hepatitis C virus-15 years on", J Gen Virol, 85, pp.3173~3188 (2004)
- Chao DT, "Systematic review: epidemiology of hepatitis C genotype 6 and its management", Aliment Pharmacol Ther, 34, pp.286~296 (2011)
- Simmonds P, "Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region", J Gen Virol, 74, pp.2391~2399 (1993)
- Nguyen MH, "Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6", Clin Gastroenterol Hepatol, 3(10 Suppl 2), pp.S97~S101 (2005)
- Kao JH, "Transmission of hepatitis C virus in Asia: past and present perspectives", J Gastroenterol Hepatol, 15(Suppl), pp.E91~E96 (2000)
- Lee GC, "Distribution of hepatitis C virus genotypes determined by line probe assay in Korean patients with chronic HCV infection", Korean J Hepatol, 4, pp.244~253 (1998)
- Zekri AR, "Hepatitis C virus genotyping in relation to neuoncoprotein overexpression and the development of hepatocellular carcinoma", J Med Microbiol, 49, pp.89~95 (2000)
- Han CJ, "Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases", Korean J Intern Med, 12, pp.21~27 (1997)
- 오덕자, "Prevalence of Hepatitis C Virus Infections and Distribution of Hepatitis C Virus Genotypes amongKorean Blood Donors", Annals of Laboratory Medicine, 32(3), pp.210~215 (2012), 대한진단검사의학회
- Seto WK, "Natural history of chronic hepatitis C: genotype 1 versus genotype 6", J Hepatol, 53, pp.444~448 (2010)
- Nguyen NH, "Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans", Hepatol Int, 4, pp.523~529 (2010)
- Akkarathamrongsin S, "Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand", J Med Virol, 82, pp.257~262 (2010)
- Wong DA, "High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong", Eur J Epidemiol, 14, pp.421~426 (1998)
- Mauss S, "Treatment results of chronic hepatitis C genotype 5 and 6 infections in Germany", Z Gastroenterol, 50, pp.441~444 (2012)
- Thu Thuy PT, "A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C", J Hepatol, 56, pp.1012~1018 (2012)
- Tangkijvanich P, "Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study", J Viral Hepat, 19, pp.423~430 (2012)